@article{Yücel_Budak_Kısa_Celik_Kozacıoglu_2018, title={The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL}, volume={90}, url={https://www.pagepressjournals.org/aiua/article/view/aiua.2018.2.104}, DOI={10.4081/aiua.2018.2.104}, abstractNote={Objective: In this study, we aimed to investigate sufficiency of 6 core prostate biopsy in patients with PSA levels elevated above 20 ng/mL. <br />Materials and methods: The medical record of the patients who received prostate biopsy at our institution between August 2011 to August 2016 who had serum total PSA values above 20 ng/mL, were reviewed retrospectively. In this study, we included 40 patients who received 6 core prostate biopsy and 40 patients who received 12 core prostate biopsy. A total number of 80 patients were enrolled in this study. Patients were divided into two groups, a 6 core biopsy group and a 12 core biopsy group. These groups are compared according to age, total PSA, prostate volume and final pathological diagnosis.<br />Results: Based on final pathological diagnosis, 2 patients (5%) had benign pathology and 38 patients (95%) had PCa in both group 1 and 2. The cancer detection rate in both groups was 95%. Although there were higher values of mean age, mean total PSA, and mean prostate volume in group 1, there was no statistically significantly difference at this variables in both groups. <br />Conclusion: Although taking 6 core biopsies is not recently recommended, we proved that 6 core biopsy is adequate for patients with PSA values above 20 ng/mL.}, number={2}, journal={Archivio Italiano di Urologia e Andrologia}, author={Yücel Cem and Budak, Salih and Kısa, Erdem and Celik, Orcun and Kozacıoglu, Zafer}, year={2018}, month={Jun.}, pages={104–106} }